Filing Flows › QHSLab (USAQ) › Q1 2026
QHSLab (USAQ) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
QHSLab (USAQ) reported revenue of $729K for the first quarter 2026 (Q1 2026), +13% from a year earlier and +4% from the quarter before. Operating margin was -13.0%, net loss $104K (14.3% of revenue).
QHSLab, Q1 2026: revenue $729K (+13% year over year), operating margin -13.0%, net loss $104K, operating cash flow −$200K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $729K | +4% | +13% |
| Operating profit | −$94K | -366% | — |
| Net earnings | −$104K | -119% | — |
| Operating cash flow | −$200K | -304% | — |
What changed
Revenue was $729K in Q1 2026, up 13% year over year and up 4% from the previous quarter. Integrated Service Program was the largest line at 51% of revenue. Integrated Service Program added $212K year over year (up 130%), 255% of the total change. Allergy Diagnostic Kit Sales declined 14%.
Gross margin was 64.6%, down 2.0 points from Q1 2025. Operating costs exceeded revenue by $94K, an operating margin of -13.0%. Operating expenses grew 28% against revenue growth of 13%. The fastest-growing cost line was Sales & marketing (+51%). The quarter ended with a net loss of $104K, after a profit of $557K the previous quarter.
Operating cash flow was −$200K. Non-cash charges added back $18K of depreciation and amortization. Working capital and other items used $114K.
Questions
What was QHSLab's revenue in the first quarter 2026?
QHSLab (USAQ) reported revenue of $729K for the first quarter 2026 (Q1 2026), +13% from a year earlier and +4% from the quarter before.
Was QHSLab profitable in the first quarter 2026?
Operating loss was $94K (-13.0% of revenue) and net loss $104K.
Source: QHSLab 10-Q on SEC EDGAR.